Skip to main content
S. 2052 118th Congress Senate

Protect Patient Access to Pharmacies Act

Official title: A bill to amend title XVIII of the Social Security Act to enforce any willing pharmacy requirements and establish safeguards to ensure patient access to pharma… Show full official titleShow less

Official title: A bill to amend title XVIII of the Social Security Act to enforce any willing pharmacy requirements and establish safeguards to ensure patient access to pharmacies in Medicare part D, and for other purposes.

Introduced: June 20, 2023 See on congress.gov
Health
Sign in to write a letter Sign in to watch
This bill died when the 118th Congress ended
It never became law before the 118th Congress (2023–2024) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 20, 2023
Read twice and referred to the Committee on Finance.
Jun 20, 2023
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action June 20, 2023

Read twice and referred to the Committee on Finance.

 Plain-English summary Congressional Research Service

Protect Patient Access to Pharmacies Act

This bill establishes certain requirements with respect to payments to pharmacies by prescription drug plan (PDP) sponsors under the Medicare prescription drug benefit and Medicare Advantage.

Specifically, the Centers for Medicare & Medicaid Services (CMS) must ensure that payments sufficiently cover a pharmacy's costs to acquire and dispense covered drugs so as to enable the pharmacy to participate as a network provider. The CMS must (1) use relevant data from pharmacies with respect to acquisition and dispensing costs for covered drugs, (2) establish payment parameters, and (3) establish an appeal process for pharmacies about payments. The CMS must also evaluate the performance measures used by PDP sponsors for pharmacy price concessions or other performance fees and develop standardized performance measures. 

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Lobbying activity 5

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

  • THE KROGER CO.
    for KROGER CO · Ohio · 1st Quarter 2026 (Jan 1 - Mar 31)
  • THE KROGER CO.
    for KROGER CO · Ohio · 4th Quarter 2025 (Oct 1 - Dec 31)
  • THE KROGER CO.
    for KROGER CO · Ohio · 3rd Quarter 2025 (July 1 - Sep 30)
  • THE KROGER CO.
    for KROGER CO · Ohio · 2nd Quarter 2025 (Apr 1 - June 30)
  • THE KROGER CO.
    for KROGER CO · Ohio · 1st Quarter 2025 (Jan 1 - Mar 31)

Bodies those filers lobbied

A filing lists the bills it worked on and the parts of government it contacted in separate sections, so these are the bodies those filers named anywhere in the filing, not a per-bill breakdown.

 Cosponsors 2
All 2 Republican 2
R
Capito, Shelley Moore
West Virginia · Jun 20, 2023
 R
Lankford, James
Oklahoma · Jun 20, 2023
Cite this page click to expand
APA
U.S. Congress. (2026). S. 2052: Protect Patient Access to Pharmacies Act. 118th Congress. Open America. https://openamerica.io/bill/118-S-2052/
MLA
"S. 2052: Protect Patient Access to Pharmacies Act." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-S-2052/.
Bluebook (legal)
S. 2052, 118th Cong. (2026), https://openamerica.io/bill/118-S-2052/.
Markdown link
[S. 2052: Protect Patient Access to Pharmacies Act](https://openamerica.io/bill/118-S-2052/)
Report a problem